Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Amortizatization of Intangibles: 2020-2021

Historic Amortizatization of Intangibles for Black Diamond Therapeutics (BDTX) over the last 2 years, with Dec 2021 value amounting to $4.0 million.

  • Black Diamond Therapeutics' Amortizatization of Intangibles rose 444.22% to $4.0 million in Q4 2021 from the same period last year, while for Dec 2021 it was $2.2 million, marking a year-over-year change of. This contributed to the annual value of $3.8 million for FY2024, which is 222.15% up from last year.
  • Latest data reveals that Black Diamond Therapeutics reported Amortizatization of Intangibles of $4.0 million as of Q4 2021, which was up 919.67% from -$488,000 recorded in Q3 2021.
  • In the past 5 years, Black Diamond Therapeutics' Amortizatization of Intangibles ranged from a high of $4.0 million in Q4 2021 and a low of -$720,000 during Q1 2021.
  • Over the past 2 years, Black Diamond Therapeutics' median Amortizatization of Intangibles value was $400,000 (recorded in 2020), while the average stood at $558,714.
  • Data for Black Diamond Therapeutics' Amortizatization of Intangibles shows a peak YoY increase of 444.22% (in 2021) and a maximum YoY decrease of 251.50% (in 2021) over the last 5 years.
  • Black Diamond Therapeutics' Amortizatization of Intangibles (Quarterly) stood at $735,000 in 2020, then spiked by 444.22% to $4.0 million in 2021.
  • Its last three reported values are $4.0 million in Q4 2021, -$488,000 for Q3 2021, and -$606,000 during Q2 2021.